References
- Sheen PC, Khetarpal VK, Cariola CM, Rowlings CE. (1995). Formulation studies of a poorly water-soluble drug in solid dispersions to improve bioavailability. Int J Pharm 118:221–227.
- Betageri GV, Makarla KR. (1995). Enhancement of dissolution of glyburide by solid dispersion and lyophilization techniques. Int J Pharm 126:155–160.
- Arias MJ, GinesJM, Moyano JR, Perez-Martinez JI, Rabasco AM. (1995). Influence of the preparation method of solid dispersions on their dissolution rate: study of triameterene–d-mannitol system. Int J Pharm 123:25–31.
- Leuner C, Dressman J. (2000). Improving drug solubility for oral delivery using solid dispersions. Eur J Pharm Biopharm 50:47–60.
- Verheyen S, Blaton N, Kinget R, Van den Mooter G. (2002). Mechanism of increased dissolution of diazepam and temazepam from polyethylene glycol 6000 solid dispersions. Int J Pharm 249:45–58.
- Okonogi S, Oguchi T, Yonemochi E, Puttipipatkhachorn S, Yamamoto K. (1997). Improved dissolution of ofloxacin via solid dispersion. Int J Pharm 156:175–180.
- Tashtoush BM, Al-Qashi ZS, Najib NM. (2004). In vitro and in vivo evaluation of glibenclamide in solid dispersion systems. Drug Dev Ind Pharm 30:601–607.
- Sethia S, Squillante E. (2004). Solid dispersion of carbamazepine in PVP K30 by conventional solvent evaporation and supercritical methods. Int J Pharm 272:1–10.
- Vogt M, Kunath K, Dressman JB. (2008). Dissolution enhancement of fenofibrate by micronization, cogrinding and spray-drying: comparison with commercial preparations. Eur J Pharm Biopharm 68:283–288.
- Perrut M, Jung J, Leboeuf F. (2005). Enhancement of dissolution rate of poorly-soluble active ingredients by supercritical fluid processes. Part I: Micronization of neat particles. Int J Pharm 288:3–10.
- Douroumis D, Fahr A. (2006). Nano- and micro-particulate formulations of poorly water-soluble drugs by using a novel optimized technique. Eur J Pharm Biopharm 63:173–175.
- Löbenberg R, Amidon GL. (2000). Modern bioavailability, bioequivalence and biopharmaceutics classification system. New scientific approaches to international regulatory standards. Eur J Pharm Biopharm 50:3–12.
- Grunenberg A, Keil B, Henck JO. (1995). Polymorphism in binary mixtures as exemplified by nimodipine. Int J Pharm 118:11–21.
- Amidon GL, Lennernäs H, Shah VP, Crison JR. (1995). A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res 12:413–420.
- Xiao D, Lin B, Mei L. (2010). Comparison of dissolution of glimepiride tablets from different manufactures. China Pharm 19:52–55.
- Moore JW, Flanner HH. (1996). Mathematical Comparison of curves with an emphasis on in vitro dissolution profiles. Pharm Tech 20:64–74.
- Costa P, Lobo JMS. (2001). Modeling and comparison of dissolution profiles. Eur J Pharm Sci 13:123–133.
- Mura P, Manderioli A, Bramanti G, Ceccarelli L. (1996). Properties of solid dispersions of naproxen in various polyethylene glycols. Drug Dev Ind Pharm 22:909–916.
- He Z, Zhong D, Chen X, Liu X, Tang X, Zhao L. (2004). Development of a dissolution medium for nimodipine tablets based on bioavailability evaluation. Eur J Pharm Sci 21:487–491.
- Lin CW, Cham TM. (1996). Effect of particle size on the available surface area of nifedipine from nifedipine polyethylene glycol 6000 solid dispersion. Drug Dev Ind Pharm 29:813–819.
- Hancock BC, Zografi G. (1997). Characteristics and significance of the amorphous state in pharmaceutical systems. J Pharm Sci 86:1–12.
- Naima Z, Chantal C, Philippe A, Siro T, Jerome D. (2001). In vitro and in vivo evaluation of carbamazepine–PEG 6000 solid dispersions. Int J Pharm 225:49–62.
- Jung JY, Yoo SD, Lee SH, Kim KH, Yoon DS, Lee KH. (1999). Enhanced solubility and dissolution rate of itraconazole by a solid dispersion technique. Int J Pharm 187:209–218.
- Zmeili S, Saket M, Qaisi A, Gharaibeh M, Amro B, Tutunji M, Razzak MA, Muti H. (1995). A comparative single-dose bioequivalence study of two brands of glipizide. Curr Ther Res 56:38–46.